Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)-Reference-Cited by-同舟云学术

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

Published:2015-08-04 Issue:8 Volume:10 Page:e0134158
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dold Leona,Ahlenstiel Golo,Althausen Eva,Luda Carolin,Schwarze-Zander Carolynne,Boesecke Christoph,Wasmuth Jan-Christian,Rockstroh Jürgen Kurt,Spengler Ulrich

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. HIV and HLA class I: An evolving relationship;PJ Goulder,2012

2. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression;AJ Frater,2007

3. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection;M Altfeld,2003

4. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors;JR Bailey,2009

5. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation;F Pereyra,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective HLA-B57: T cell and natural killer cell recognition in HIV infection;Biochemical Society Transactions;2022-09-16

2. Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV;PLOS ONE;2021-08-09

3. The Importance of Regulation in Natural Immunity to HIV;Vaccines;2021-03-18

4. TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients;Journal of Molecular Medicine;2020-12-05

5. Frequency and Duration of Incarceration and Mortality Among US Veterans With and Without HIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2020-06-01